|
1
|
Achrol AS, Rennert RC, Anders C, Soffietti
R, Ahluwalia MS, Nayak L, Peters S, Arvold ND, Harsh GR, Steeg PS
and Chang SD: Brain metastases. Nat Rev Dis Primer. 5:52019.
View Article : Google Scholar
|
|
2
|
Sperduto PW, Kased N, Roberge D, Xu Z,
Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, et al: Summary
report on the graded prognostic assessment: An accurate and facile
diagnosis-specific tool to estimate survival for patients with
brain metastases. J Clin Oncol. 30:419–425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lowery FJ and Yu D: Brain metastasis:
Unique challenges and open opportunities. Biochim Biophys Acta Rev
Cancer. 1867:49–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsukada Y, Fouad A, Pickren JW and Lane
WW: Central nervous system metastasis from breast carcinoma.
Autopsy study. Cancer. 52:2349–2354. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nayak L, Lee EQ and Wen PY: Epidemiology
of brain metastases. Curr Oncol Rep. 14:48–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tabouret E, Chinot O, Metellus P, Tallet
A, Viens P and Gonçalves A: Recent trends in epidemiology of brain
metastases: An overview. Anticancer Res. 32:4655–4662.
2012.PubMed/NCBI
|
|
7
|
Schardt JA, Meyer M, Hartmann CH, Schubert
F, Schmidt-Kittler O, Fuhrmann C, Polzer B, Petronio M, Eils R and
Klein CA: Genomic analysis of single cytokeratin-positive cells
from bone marrow reveals early mutational events in breast cancer.
Cancer Cell. 8:227–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hüsemann Y, Geigl JB, Schubert F, Musiani
P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G and
Klein CA: Systemic spread is an early step in breast cancer. Cancer
Cell. 13:58–68. 2008. View Article : Google Scholar
|
|
9
|
Harper KL, Sosa MS, Entenberg D, Hosseini
H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis
RJ, et al: Mechanism of early dissemination and metastasis in
Her2+ mammary cancer. Nature. 540:588–592. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goss PE and Chambers AF: Does tumour
dormancy offer a therapeutic target? Nat Rev Cancer. 10:871–877.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sosa MS, Bragado P and Aguirre-Ghiso JA:
Mechanisms of disseminated cancer cell dormancy: An awakening
field. Nat Rev Cancer. 14:611–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giancotti FG: Mechanisms governing
metastatic dormancy and reactivation. Cell. 155:750–764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao H, Chakraborty G, Lee-Lim AP, Mo Q,
Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH and Giancotti FG:
The BMP inhibitor coco reactivates breast cancer cells at lung
metastatic sites. Cell. 150:764–779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Connell JT, Sugimoto H, Cooke VG,
MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR,
Resnick MB, et al: VEGF-A and Tenascin-C produced by S100A4+
stromal cells are important for metastatic colonization. Proc Natl
Acad Sci USA. 108:16002–16007. 2011. View Article : Google Scholar
|
|
17
|
Gao D, Nolan DJ, Mellick AS, Bambino K,
McDonnell K and Mittal V: Endothelial progenitor cells control the
angiogenic switch in mouse lung metastasis. Science. 319:195–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguirre-Ghiso JA, Ossowski L and Rosenbaum
SK: Green fluorescent protein tagging of extracellular
signal-regulated kinase and p38 pathways reveals novel dynamics of
pathway activation during primary and metastatic growth. Cancer
Res. 64:7336–7345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsai JH, Donaher JL, Murphy DA, Chau S and
Yang J: Spatiotemporal regulation of epithelial-mesenchymal
transition is essential for squamous cell carcinoma metastasis.
Cancer Cell. 22:725–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Q, Zhang H, Jiang X, Qian C, Liu Z and
Luo D: Factors involved in cancer metastasis: A better
understanding to ‘seed and soil’ hypothesis. Mol Cancer.
16:1762017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Demicheli R, Biganzoli E, Boracchi P,
Greco M and Retsky MW: Recurrence dynamics does not depend on the
recurrence site. Breast Cancer Res. 10:R832008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Retsky MW, Demicheli R, Swartzendruber DE,
Bame PD, Wardwell RH, Bonadonna G, Speer JF and Valagussa P:
Computer simulation of a breast cancer metastasis model. Breast
Cancer Res Treat. 45:193–202. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klein CA: Selection and adaptation during
metastatic cancer progression. Nature. 501:365–372. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bilous M, Serdjebi C, Boyer A, Tomasini P,
Pouypoudat C, Barbolosi D, Barlesi F, Chomy F and Benzekry S:
Quantitative mathematical modeling of clinical brain metastasis
dynamics in non-small cell lung cancer. Sci Rep. 9:130182019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun YW, Xu J, Zhou J and Liu WJ: Targeted
drugs for systemic therapy of lung cancer with brain metastases.
Oncotarget. 9:5459–5472. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leyland-Jones B: Human epidermal growth
factor receptor 2-positive breast cancer and central nervous system
metastases. J Clin Oncol. 27:5278–5286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piura E and Piura B: Brain Metastases from
Ovarian Carcinoma. ISRN Oncol. 5274532011.PubMed/NCBI
|
|
28
|
Demicheli R, Retsky MW, Hrushesky WJ and
Baum M: Tumor dormancy and surgery-driven interruption of dormancy
in breast cancer: Learning from failures. Nat Clin Pract Oncol.
4:699–710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neophytou CM, Kyriakou TC and Papageorgis
P: Mechanisms of metastatic tumor dormancy and implications for
cancer therapy. Int J Mol Sci. 20:61582019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aguirre-Ghiso JA, Liu D, Mignatti A,
Kovalski K and Ossowski L: Urokinase receptor and fibronectin
regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine
carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell.
12:863–879. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yeh AC and Ramaswamy S: Mechanisms of
cancer cell dormancy-another hallmark of cancer? Cancer Res.
75:5014–5022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghajar CM, Peinado H, Mori H, Matei IR,
Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY,
et al: The perivascular niche regulates breast tumour dormancy. Nat
Cell Biol. 15:807–817. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valiente M, Obenauf AC, Jin X, Chen Q,
Zhang XHF, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E and Massagué
J: Serpins promote cancer cell survival and vascular co-option in
brain metastasis. Cell. 156:1002–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schulz M, Salamero-Boix A, Niesel K,
Alekseeva T and Sevenich L: Microenvironmental regulation of tumor
progression and therapeutic response in brain metastasis. Front
Immunol. 10:17132019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Priego N, Zhu L, Monteiro C, Mulders M,
Wasilewski D, Bindeman W, Doglio L, Martínez L, Martínez-Saez E,
Ramón Y, et al: STAT3 labels a subpopulation of reactive astrocytes
required for brain metastasis. Nat Med. 24:1024–1035. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lorger M and Felding-Habermann B:
Capturing changes in the brain microenvironment during initial
steps of breast cancer brain metastasis. Am J Pathol.
176:2958–2971. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmidt-Kittler O, Ragg T, Daskalakis A,
Granzow M, Ahr A, Blankenstein TJF, Kaufmann M, Diebold J, Arnholdt
H, Muller P, et al: From latent disseminated cells to overt
metastasis: Genetic analysis of systemic breast cancer progression.
Proc Natl Acad Sci USA. 100:7737–7742. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kobayashi A, Okuda H, Xing F, Pandey PR,
Watabe M, Hirota S, Pai SK, Liu W, Fukuda K, Chambers C, et al:
Bone morphogenetic protein 7 in dormancy and metastasis of prostate
cancer stem-like cells in bone. J Exp Med. 208:2641–2655. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Aguirre-Ghiso JA, Bragado P and Sosa MS:
Metastasis awakening: Targeting dormant cancer. Nat Med.
19:276–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Noh T and Walbert T: Brain metastasis:
Clinical manifestations, symptom management, and palliative care.
Handb Clin Neurol. 149:75–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
D'Ambrosio AL and Agazzi S: Prognosis in
patients presenting with brain metastasis from an undiagnosed
primary tumor. Neurosurg Focus. 22:E72007. View Article : Google Scholar
|
|
42
|
Rostami R, Mittal S, Rostami P, Tavassoli
F and Jabbari B: Brain metastasis in breast cancer: A comprehensive
literature review. J Neurooncol. 127:407–414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kuremsky JG, Urbanic JJ, Petty WJ, Lovato
JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG and Chan
MD: Tumor histology predicts patterns of failure and survival in
patients with brain metastases from lung cancer treated with gamma
knife radiosurgery. Neurosurgery. 73:641–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vern-Gross TZ, McMullen KP, Case LD,
Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ
and Chan MD: Patterns of failure in patients receiving gamma knife
radiosurgery for breast carcinoma to the brain. Int J Radiat Oncol.
81 (Suppl):S216–S217. 2011. View Article : Google Scholar
|
|
45
|
Davies MA, Saiag P, Robert C, Grob JJ,
Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T,
Mortier L, et al: Dabrafenib plus trametinib in patients with
BRAFV600-mutant melanoma brain metastases (COMBI-MB): A
multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol.
18:863–873. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim DW, Tiseo M, Ahn MJ, Reckamp KL,
Hansen KH, Kim SW, Huber RM, West HL, Groen HJM, Hochmair MJ, et
al: Brigatinib in patients with crizotinib-refractory anaplastic
lymphoma kinase-positive non-small-cell lung cancer: A randomized,
multicenter phase II trial. J Clin Oncol. 35:2490–2498. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iuchi T, Shingyoji M, Sakaida T, Hatano K,
Nagano O, Itakura M, Kageyama H, Yokoi S, Hasegawa Y, Kawasaki K
and Iizasa T: Phase II trial of gefitinib alone without radiation
therapy for Japanese patients with brain metastases from
EGFR-mutant lung adenocarcinoma. Lung Cancer. 82:282–287. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Patchell RA, Tibbs PA, Walsh JW, Dempsey
RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS and Young
B: A randomized trial of surgery in the treatment of single
metastases to the brain. N Engl J Med. 322:494–500. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin X and DeAngelis LM: Treatment of brain
metastases. J Clin Oncol. 33:3475–3484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Soffietti R, Abacioglu U, Baumert B, Combs
SE, Kinhult S, Kros JM, Marosi C, Metellus P, Radbruch A, Freixa
SSV, et al: Diagnosis and treatment of brain metastases from solid
tumors: Guidelines from the european association of neuro-oncology
(EANO). Neuro Oncol. 19:162–174. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ekici K, Temelli O, Dikilitas M, Halil
Dursun I, Bozdag Kaplan N and Kekilli E: Survival and prognostic
factors in patients with brain metastasis: Single center
experience. J BUON. 21:958–963. 2016.PubMed/NCBI
|
|
53
|
Chao ST, Barnett GH, Liu SW, Reuther AM,
Toms SA, Vogelbaum MA, Videtic GMM and Suh JH: Five-year survivors
of brain metastases: A single-institution report of 32 patients.
Int J Radiat Oncol Biol Phys. 66:801–809. 2006. View Article : Google Scholar : PubMed/NCBI
|
